Siegfried Breaks Ground for Global R&D Center
Swiss-based, globally oriented CDMO Siegfried has broken ground or its new global Research and Development (R&D) Center for Drug Substances at its site in Evionnaz, Switzerland, which the company describes as a “key pillar” in its related network.
From left: Sophia Dini (State Council Delegate for Economy and Innovation), Beat Rieder (Council of State VS, Die Mitte), Valerie Santacrocce-Tachini (President of the municipality Evionnaz), Wolfgang Wienand (CEO Siegfried), Marcel Signer (Site Head Siegfried Evionnaz), Irene Wosgien (COO DS Siegfried), Jürgen Roos (CSO Siegfried), Andreas Casutt (VRP Siegfried) © Siegfried
The new center, costing as much as 25 million Swiss francs to build, is set to begin operations in 2024 with 100 “highly skilled specialists.” Together with the research center at its home base in zofingen, Siegfried said the new facility will “significantly increase R&D capacity to drive future growth.“
With its advanced chemical and analytical facilities and state-of-the-art laboratories, the center will offer chemical process R&D and analytical development services for the entire drug substances network. CEO Wolfgang Wienand said the facility center will not only strengthen its site in Evionnaz, but also its global network.
Author: Dede Williams, Freelance Journalist
